Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions

The coronavirus disease 2019 (COVID-19) (caused by severe acute respiratory syndrome coronavirus 2) pandemic has massively distorted our health care systems and caused catastrophic consequences in our affected communities. The number of victims continues to increase, and patients at risk can only be...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Allergy Clin Immunol
Autors principals: Valent, Peter, Akin, Cem, Bonadonna, Patrizia, Brockow, Knut, Niedoszytko, Marek, Nedoszytko, Boguslaw, Butterfield, Joseph H., Alvarez-Twose, Ivan, Sotlar, Karl, Schwaab, Juliana, Jawhar, Mohamad, Reiter, Andreas, Castells, Mariana, Sperr, Wolfgang R., Kluin-Nelemans, Hanneke C., Hermine, Olivier, Gotlib, Jason, Zanotti, Roberta, Broesby-Olsen, Sigurd, Horny, Hans-Peter, Triggiani, Massimo, Siebenhaar, Frank, Orfao, Alberto, Metcalfe, Dean D., Arock, Michel, Hartmann, Karin
Format: Artigo
Idioma:Inglês
Publicat: The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7297685/
https://ncbi.nlm.nih.gov/pubmed/32561389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.06.009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars